Exova Group Plc (LON: EXO) has recently received a number of price target changes and ratings updates:

  • 9/1/2016 – Exova Group Plc had its price target lowered by analysts at Goldman Sachs Group Inc. from GBX 219 ($2.86) to GBX 210 ($2.74). They now have a “buy” rating on the stock.
  • 9/1/2016 – Exova Group Plc had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a GBX 225 ($2.94) price target on the stock.
  • 8/31/2016 – Exova Group Plc had its “buy” rating reaffirmed by analysts at Shore Capital.
  • 8/31/2016 – Exova Group Plc had its price target raised by analysts at Peel Hunt from GBX 170 ($2.22) to GBX 210 ($2.74). They now have an “add” rating on the stock.

Shares of Exova Group Plc (LON:EXO) opened at 200.00 on Tuesday. The company’s market cap is GBX 500.80 million. Exova Group Plc has a 52-week low of GBX 123.00 and a 52-week high of GBX 210.00. The stock’s 50 day moving average price is GBX 199.96 and its 200-day moving average price is GBX 178.71.

The company also recently announced a dividend, which will be paid on Wednesday, November 9th. Stockholders of record on Thursday, October 27th will be paid a dividend of GBX 1.05 ($0.01) per share. The ex-dividend date is Thursday, October 27th. This represents a dividend yield of 0.53%.

Exova Group plc is a United Kingdom-based provider of laboratory-based testing and related advisory services, operating from approximately 121 laboratories in around 23 countries. The Company has three operational segments, which include Europe, the Americas and Rest of World. The Company provides services across five business clusters, such as Aerospace; Oil and Gas, and Industrials; Product; Health Sciences, and Middle East.

Receive News & Ratings for Exova Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exova Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.